← Back to Search

Green Tea and Milk Thistle Supplements for Colon Cancer

Phase 1
Waitlist Available
Led By Richard L Whelan, MD
Research Sponsored by Richard Whelan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Study Summary

This trial will test whether it is safe to give a green tea extract and milk thistle extract to colorectal cancer patients in the weeks before and after surgery.

Eligible Conditions
  • Colon Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of patients with adverse events or complications

Trial Design

1Treatment groups
Experimental Treatment
Group I: Green Tea and Milk Thistle SupplementsExperimental Treatment1 Intervention
Patients will receive green tea extract and milk thistle extract supplements for one week prior to surgery and for 30 days after surgery.

Find a Location

Who is running the clinical trial?

Richard WhelanLead Sponsor
St. Luke's-Roosevelt Hospital CenterOTHER
95 Previous Clinical Trials
18,313 Total Patients Enrolled
Richard L Whelan, MDPrincipal InvestigatorMount Sinai St. Luke's Roosevelt Hospital
2 Previous Clinical Trials
79 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby May 2025